Tag Archives: healthcare

A Manhattan Project for Alzheimer’s Disease

James Greenwood STILL 5_EDIT

Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & CEO Jim Greenwood highlighted the need for our nation to think bigger about how we approach Alzheimer’s Disease. Greenwood called for a “Manhattan Project” to rally the country around addressing this growing health challenge.  He also noted that addressing Alzheimer’s Disease is the type of issue that could bring together elected officials on both sides of the aisle. As part Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , ,

Bridging Research to Cures: Summit for R&D Companies

admin-ajax copy

As human and animal health companies struggle to advance medical innovation while managing costs, the outsourcing of research and development functions has become a critical strategy for success. BioResearch Central provides the outsourcing resources needed to accelerate healthcare innovation, to reach patients faster. Born of the legacy of Marion Laboratories and supported by a highly experienced workforce, BioResearch Central companies provide a breadth of services including discovery, toxicology, bioanalytics, clinical trials, regulatory and commercial support. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Patient and Health Advocacy Summit: Patient-Focused Drug Development

95468934

Panelists in this morning’s opening session outlined strategies for the FDA to better engage the patient community to guide the drug development process. “Patients should be providing input and guidance throughout the entire drug review process,” said Marc Boutin, Executive VP and COO of the National Health Council. Boutin highlighted the improvements made through PDUFA V to open up and enhance the Agency’s interaction and engagement with patients. “Integrating our perspective into how drugs are Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Uniting To Accelerate Pediatric Medicine

Erik_Halvorsen

Drug companies inherently absorb significant risk when developing compounds and biologics for clinical use. A recent article suggests that only one out of every 12 drugs that enters clinical trials succeeds and the cost of a drug successfully reaching the market now exceeds an average of $5 billion when you add up the cost of all those that failed along the way. For many indications, such as Alzheimer’s and autism, the need for new treatments Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

New CDC Report on Alarming Rates of Antibiotic-Resistant Infections

MRSA

Every year in the United States, 2 million people acquire an antibiotic-resistant infection. Of those, at least 23,000 die as a result. That’s according to an alarming report  released last week by the CDC. Antibiotic resistance is one of the largest threats to global health. The prevalence of antibiotic-resistant infections is not only a serious world-wide public health issue, it also adds considerable costs to the U.S. healthcare system. According to the CDC: Studies have estimated Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,